Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

September
09
2022

Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference

BOCA RATON, Fla., Sept. 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will…

September
07
2022

Sensus Healthcare Adds Dr. Mohammad K. Khan to Medical Advisory Board

Addition of World-Renowned Radiation Oncologist Deepens Pool of Expertise BOCA RATON, Fla., Sept. 07, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments…

August
09
2022

Sensus Healthcare Launches Upgrade to its SRT-100 Vision System with New State-of-the-Art Ultrasound Capabilities

Includes a new ergonomic probe to operate in ideal MHz range to view all layers of skin BOCA RATON, Fla, Aug. 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in…

August
04
2022

Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124%

Diluted EPS of $0.21 compares with $(0.02) for the year-ago quarter Affirms expectations for full-year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 04, 2022 — Sensus Healthcare, Inc….

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy